Safety Study of BMS-770767 in Subjects With Hypercholesterolemia
NCT01058083
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
81
Enrollment
INDUSTRY
Sponsor class
Conditions
Dyslipidemia
Interventions
DRUG:
BMS-770767
DRUG:
BMS-770767
DRUG:
BMS-770767
DRUG:
BMS-770767
DRUG:
Placebo
Sponsor
Bristol-Myers Squibb